Lee Ainslie’s GSK GSK Stock Holding History

Lee Ainslie’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-22,816	Closed	-$1.16M	–	140
2016 Q1	$1.16M	Buy	+22,816	New	+$1.14M	0.02%	94

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Lee Ainslie's GSK Position: Q2 2016 in Review

Lee Ainslie sold out of GSK (GSK) in Q2 2016, closing a stake of 22,816 shares — an estimated $1.16M sold.

Lee Ainslie first reported a position in GSK in Q1 2016 and held it in 1 quarter. The position peaked at $1.16M in Q1 2016. 742 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

Lee Ainslie reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
Lee Ainslie sold 22,816 GSK shares in Q2 2016, an estimated $1.16M.
Lee Ainslie first reported a position in GSK in Q1 2016 and held it in 1 quarter.
Lee Ainslie's GSK position peaked at $1.16M in Q1 2016.
742 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on Maverick Capital's 13F filing for Q2 2016, filed 15 Aug 2016.